We report a Dressing Supplies 55-year-old men patient with a primitive central nervous system non-Hodgkin lymphoma B cell (LNH PNSLC), treated with chemotherapy rituximab, methotrexate, and ibrutinib (first treatment) who developed a refractory ventricular arrhythmic storm two hours after the ibrutinib intake.Indeed, ibrutinib could be associated with severe and occasionally fatal cardiac events.The swift emergence of a ventricular electrical storm with cardiac arrest demanded the prompt initiation of veno-arterial extracorporeal membrane oxygenation to Isolator effectively navigate this critically ill patient toward recovery.This intervention was deemed imperative, given the absence of any available antidote for the effects of ibrutinib.Veno-arterial extracorporeal membrane oxygenation proved successful in rescuing this patient, resulting in a complete neurological recovery.
Consequently, he was able to resume his chemotherapy treatment.